Assertio Holdings Inc. released a presentation highlighting its sustainable long-term growth strategy centered around commercial pharmaceutical assets. The company emphasizes its adaptable, market-agnostic capabilities and positive cash flow from operations, which support both organic and strategic growth initiatives. Assertio is well-capitalized to facilitate strategic deals aimed at enhancing scale and diversifying its platform. The leadership team, with extensive commercial execution and business development experience, has been strengthened to support transformation and future growth. The organization is focused on streamlining expenses and prioritizing core assets while seeking strategic opportunities to adapt to the rapidly changing operating environment. You can access the full presentation through the link below.